BeOne Medicines (ONC) Inventory (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Inventory data on file, last reported at $681.6 million in Q1 2026.

• Quarterly Inventory rose 37.79% year-over-year to $681.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $681.6 million (up 37.79% YoY) and the FY2025 annual result came in at $608.2 million, up 22.88% from the prior year.
• Inventory rose to $681.6 million in Q1 2026 per ONC's latest filing, from $608.2 million in the prior quarter.
• Across five years, Inventory topped out at $681.6 million in Q1 2026 and bottomed at $245.6 million in Q1 2022.
• The 5-year median for Inventory is $431.7 million (2024), against an average of $415.8 million.
• The widest annual swing landed in 2022, when Inventory soared 236.6%; it then grew 8.94% in 2023.
• Tracing ONC's Inventory over 5 years: stood at $282.3 million in 2022, then jumped by 47.38% to $416.1 million in 2023, then rose by 18.95% to $495.0 million in 2024, then rose by 22.88% to $608.2 million in 2025, then rose by 12.06% to $681.6 million in 2026.
• Per Business Quant, the three latest ONC Inventory figures stand at $681.6 million (Q1 2026), $608.2 million (Q4 2025), and $531.7 million (Q3 2025).

Peer Comparison